As shown in Fig. 5e, the treatment with IDO1 inhibitors restored the elevated levels of leukemia blast cells and lower levels of red blood cells and mature neutrophils in AML model mice to the levels similar to non-AML. Here, IDO1 is linked to acute myeloid leukemia.